WHO Tag

04 Nov SAHPRA-WHO Webinar | Implementation of National Action Plan for fighting SF Medical Products

Posted at 10:19h in

The South African Health Products Regulatory Authority (SAHPRA), in conjunction with the World Health Organization (WHO) is introducing the WHO Pilot on Implementation of the National Action Plan on fighting substandard and falsified (SF) medical products in South Africa. This webinar is aimed at sensitising key...

Read More

13 Nov Good Regulatory Practices and Technical Competencies

Posted at 11:49h in

This workshop will provide an exchange of information and capacity building between the South African Health Products Regulatory Authority, SAPHRA and partner reference NRAs including the WHO, USFDA, TGA, HSA, ANVISA, covering the core international references for medical device regulatory. The workshop objective is to...

Read More

Photo by Syaibatul Hamdi | Pixabay

15 May SAHPRA perspectives on Coronavirus SARS-COV-2

Posted at 21:59h in News & Updates, Press Releases

Share

Pretoria, 15 May 2023 -The South Africa Health Products Regulatory Authority (SAHPRA) acknowledges and aligns itself to the statement issued by the World Health Organization (WHO) Director-General, declaring an end to the Public Health Emergency of International Concern (PHEIC) for the disease caused by the...

Read More

© SAHPRA

23 Feb SAHPRA hosts Regional QMS Technical Working Group Workshop

Posted at 08:53h in News & Updates

Share

Pretoria, 23 February 2023 - The South African Health Products Regulatory Authority (SAHPRA) hosted the Regional Quality Management Systems (QMS) Technical Working Group Workshop during 20 - 23 February 2023 at Protea Hotel – OR Tambo Airport. The participating countries included: Angola, Botswana, Eswatini, Lesotho,...

Read More

19 Oct SAHPRA unpacks global accolade upon receiving WHO Maturity Level 3 (ML3)

Posted at 09:59h in

The South African Health Products Regulatory Authority (SAHPRA) hosted a conversation on our recent accolade of attaining the World Health Organisation (WHO) Maturity Level 3 (ML3) for vaccine production. We had invited some of our Executives, CEO Dr. Boitumelo Semete-Makokotlela, CRO Portia Nkambule, and COO Christelna...

Read More

Pixabay via Unsplash

10 Oct SAHPRA alerts the public about contaminated health products

Posted at 15:46h in News & Updates, Press Releases

Share

Pretoria, 10 October 2022 – The South African Health Products Regulatory Authority (SAHPRA), like other regulators globally, has been alerted to dubious health products being traded by an Indian company, Maiden Pharmaceuticals. The products as they appear on the World Health Organisation (WHO) product list (Medical...

Read More

World Health Organisation

05 Oct SAHPRA receives Accolade from the World Health Organisation

Posted at 14:48h in News & Updates, Press Releases

Share

Pretoria, 5 October 2022 - The South African Health Products Regulatory Authority (SAHPRA) has recently been ranked by the World Health Organisation (WHO) at a functional level of maturity (Level 3) according to WHO’s global classification system for national medical products regulatory authorities. This means...

Read More

18 Sep SAHPRA acknowledges World Patient Safety Day

Posted at 14:40h in News & Updates

Share

Patient safety resonates with SAHPRA’s mission of ensuring that the public is protected by registering and regulating all health products so that they comply with SAHPRA’s pillars of safety, quality, efficacy and performance. This involves ensuring that stringent regulatory requirements are followed before any health product is made...

Read More

23 Jun Learn more about monkeypox as we record first confirmed case in SA

Posted at 09:54h in News & Updates

Share

SamuelFrancisJohnson via Pixabay...

Read More

11 Jun SAHPRA Represented at A side event at the 30th Commission on Crime Prevention and Criminal Justice

Posted at 14:31h in News & Updates

Share

11 June 2021 Background World Health Organization (WHO) estimates from 2017 indicates that 10.5% of medical products available in low- and middle-income countries (LMICs) are “substandard or falsified” (SF). Substandard health products are approved by the national regulators, but they do not comply with adequate standards due...

Read More